Supernus Pharmaceuticals | SUPN - 债务

金融业

USD

USD 1.5B

现金及等价物

USD 184.87M

USD 49.04M

USD 731.58M

USD 373.93M

USD 40.98M

USD -35.25M

USD 29.23M

674

EPS每股收益

USD 0.6

股本和储备

USD 1.08B

USD 129.36M

债务利息支出

USD 910K

USD 2.02M

USD 400.38M

USD 2.55B

USD -2.29M

USD 1.08B

USD -35.25M

普通股股本

USD 58.04M

44.21

USD -5.95M

USD 207.71M

销售和管理费用

USD 118.23M

USD 110.77M

贸易债权人

USD 10.17M

应收帐款人

USD 182.18M

	债务	更改		日
Abbott	USD 34.05B		20.19B	2026-03
ANI Pharmaceuticals	USD 617.04M		3.28M	2025-12
Aurora Cannabis	CAD 23.86M		76.48M	2026-03
Bristol-Myers Squibb	USD 46.43B		711M	2026-03
Canopy Growth	CAD 278.71M		19.38M	2026-03
Cara Therapeutics	USD 0		0	2025-03
Corcept Therapeutics	USD 9.64M		3.53M	2026-03
Eisai	JPY 236.67B		49.14B	2025-09
Eli Lilly	USD 42.5B		3.6M	2025-12
Novo Nordisk	DKK 118.72B		61.75B	2025-03
Pacira	USD 367.66M		4.53M	2026-03
Perrigo	USD 3.64B		4.5M	2025-12
Pfizer	USD 63.73B		231M	2026-03
Supernus Pharmaceuticals	USD 40.98M		1.23M	2025-12
United Therapeutics	USD 200M		100M	2025-03
Xeris Pharmaceuticals	USD 258.55M		899K	2026-03